New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 13, 2014
13:59 EDTDRTXDurata Therapeutics CEO buys 3,000 shares
Durata Therapeutics CEO Paul Edick purchased 3,000 shares of the company's stock at a price of $15.23 each on June 12, according to a regulatory filing.
News For DRTX From The Last 14 Days
Check below for free stories on DRTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 18, 2014
08:06 EDTDRTXDurata Therapeutics announces U.S. launch of Dalvance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use